Authors: Hoganson, DK Sosnowski, BA Pierce, GF Doukas, J

Citation: Dk. Hoganson et al., Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand, MOL THER, 3(1), 2001, pp. 105-112

Authors: Doukas, J Chandler, LA Gonzalez, AM Gu, DL Hoganson, DK Ma, CL Nguyen, T Printz, MA Nesbit, M Herlyn, M Crombleholme, TM Aukerman, SL Sosnowski, BA Pierce, GF

Citation: J. Doukas et al., Matrix immobilization enhances the tissue repair activity of growth factorgene therapy vectors, HUM GENE TH, 12(7), 2001, pp. 783-798

Authors: Chandler, LA Doukas, J Gonzalez, AM Hoganson, DK Gu, DL Ma, CL Nesbit, M Crombleholme, TM Herlyn, M Sosnowski, BA Pierce, GF

Citation: La. Chandler et al., FGF2-targeted adenovirus encoding platelet-derived growth factor-B enhances de Novo tissue formation, MOL THER, 2(2), 2000, pp. 153-160

Authors: Doukas, J Hoganson, DK Ong, M Ying, WB Lacey, DL Baird, A Pierce, GF Sosnowski, BA

Citation: J. Doukas et al., Retargeted delivery of adenoviral vectors through fibroblast growth factorreceptors involves unique cellular pathways, FASEB J, 13(11), 1999, pp. 1459-1466

Authors: Gu, DL Gonzalez, AM Printz, MA Doukas, J Ying, WB D'Andrea, M Hoganson, DK Curiel, DT Douglas, JT Sosnowski, BA Baird, A Aukerman, SL Pierce, GF

Citation: Dl. Gu et al., Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: Evidence for reduced toxicity and enhanced antitumor activity in mice, CANCER RES, 59(11), 1999, pp. 2608-2614

Authors: Hoganson, DK Williams, AW Berger, SH

Citation: Dk. Hoganson et al., Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line, BIOCH PHARM, 58(10), 1999, pp. 1529-1537